Oral Contraceptive Clinical Trial
Official title:
The Effects of Dose and Formulation of Oral Contraceptives (OCs) on Breast-Cell Proliferation: Can the Chemopreventive Effects of OCs on Endometrial and Ovarian Cancer be Extended to Breast Cancer?
The purpose of this research study is to gain a better understanding of the changes that may occur in the breast when a woman uses an oral contraceptive (birth control pill). Some research indicates that women who use birth control pills with lower amounts of estrogen (a hormone in the birth control pill) may have lower breast cell growth than women who use birth control pills with a higher amount of estrogen; this research will examine that in detail. This research will also test whether the results found in HS-07-00269 can be confirmed.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01388491 -
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
|
Phase 2 | |
Completed |
NCT01252186 -
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
|
Phase 2 | |
Not yet recruiting |
NCT06426459 -
Social Media Usage in Adolescent Girls
|
||
Recruiting |
NCT02398903 -
Evaluation of Hormonal Contraceptive Treatments in Obese Women
|
||
Completed |
NCT00302666 -
Bleeding Pattern Study
|
Phase 3 | |
Completed |
NCT00739622 -
TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
|
Phase 1 | |
Completed |
NCT01291004 -
A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
|
Phase 1 | |
Recruiting |
NCT02021097 -
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
|
Phase 3 | |
Completed |
NCT00778609 -
Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
|
Phase 3 | |
Completed |
NCT00972439 -
Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
|
N/A | |
Completed |
NCT01076582 -
Comparative Trial in Hormone Withdrawal Associated Symptoms
|
Phase 3 | |
Completed |
NCT00471991 -
Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition
|
Phase 2 | |
Completed |
NCT00248963 -
Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception
|
Phase 3 |